作者：
Chiara,Whichello [1]
;
Eline,van Overbeeke [2]
;
Rosanne,Janssens [2]
;
Karin,Schölin Bywall [3]
;
Selena,Russo [4]
;
Jorien,Veldwijk [1]
;
Irina,Cleemput [5]
;
Juhaeri,Juhaeri [6]
;
Bennett,Levitan [7]
;
Jürgen,Kübler [8]
;
Meredith,Smith [9]
;
Richard,Hermann [10]
;
Matthias,Englbrecht [11]
;
Axel J,Hueber [11]
;
Alina,Comanescu [12]
;
Sarah,Harding [13]
;
Steven,Simoens [2]
;
Isabelle,Huys [2]
;
Esther W,de Bekker-Grob [1]
作者单位：
Erasmus School of Health Policy & Management and Erasmus Choice Modelling Centre, Erasmus University, Rotterdam, Netherlands.
[1]
Department of Pharmaceutical and Pharmacological Sciences, University of Leuven, Leuven, Belgium.
[2]
Center for Research Ethics & Bioethics, Uppsala University, Uppsala, Sweden.
[3]
Applied Research Division for Cognitive and Psychological Science, IEO European Institute of Oncology IRCCS, Milan, Italy.
[4]
Belgian Health Care Knowledge Centre, Brussels, Belgium.
[5]
Sanofi, Bridgewater, NJ, United States.
[6]
Global R&D Epidemiology, Janssen Research & Development, Titusville, United States.
[7]
Quantitative Scientific Consulting, Marburg, Germany.
[8]
Global Patient Safety and Labeling, Amgen Inc., Thousand Oaks, CA, United States.
[9]
Astra Zeneca, Gaithersburg, MD, United States.
[10]
Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany.
[11]
Community Health Association, Bucharest, Romania.
[12]
Global Patient Safety, Takeda, London, United Kingdom.
[13]
DOI
10.3389/fphar.2019.01009
PMID
31619989
发布时间
2020-09-30
换一批
换一批
